Upload Button Icon Add office photos
filter salariesFilter salaries by

Prime Therapeutics Clinical Reviewer salaries in India (Updated 2025)

Annual salary range
Select experience
₹3.5 Lakhs - ₹4.4 Lakhs
Low Confidence
info icon
Low confidence means that this average salary is based on data that was reported by very few people.
Salary of majority employees
unlock blur
unlock blur

Interested in this particular role?

Last Updated: 18 Feb 2025

Companies similar to Prime Therapeutics for Clinical Reviewer

Company name Avg Annual Salary Open Jobs
Logo
Cognizant Clinical Reviewer Salary

10 - 13 years exp. (5 salaries)

unlock blur

₹12.5 L/yr - ₹17 L/yr

arrow icon 255% more
Logo
Accenture Clinical Reviewer Salary

2 - 5 years exp. (3 salaries)

unlock blur

₹6.2 L/yr - ₹7 L/yr

arrow icon 66% more
Logo
EXL Service Clinical Reviewer Salary

0 - 3 years exp. (24 salaries)

unlock blur

₹2.4 L/yr - ₹3.5 L/yr

arrow icon 34% less
Logo
HGS Clinical Reviewer Salary

1 - 8 years exp. (12 salaries)

unlock blur

₹2.2 L/yr - ₹6.3 L/yr

arrow icon 9% more
unlock blur

₹5 L/yr - ₹7.3 L/yr

arrow icon 47% more
Clinical Reviewer salary at Prime Therapeutics ranges between ₹3.5 Lakhs to ₹4.4 Lakhs per year for employees with 1 year of experience. Salary estimates are based on 1 latest salaries received from various employees of Prime Therapeutics.

Discover interview dos and don'ts from real experiences

Prime Therapeutics Clinical Reviewer Salary FAQs

How the salary growth look like for a Clinical Reviewer at Prime Therapeutics in India?
The salary growth for a Clinical Reviewer at Prime Therapeutics depends on factors such as experience, performance, and promotions. On average, a Clinical Reviewer can expect the following growth trajectory at Prime Therapeutics:

Experience Average Salary Range
1 year ₹3.5 Lakhs to ₹4.4 Lakhs per year
and so on.

Tell us how to improve this page.

Prime Therapeutics Clinical Reviewer salary in India ranges between ₹3.5 Lakhs to ₹4.4 Lakhs. This is an estimate based on latest salaries received from employees of Prime Therapeutics.